Brand refresh reflects growing industry focus on protecting patient affordability investments and improving visibility across the Gross-to-Net ecosystem IRVINE, Calif.–(BUSINESS WIRE)–#GTN—RIS Rx today announced a new brand identity and messaging platform reflecting its expanding role in addressing one of the pharmaceutical industry’s most persistent financial and operational challenges: Gross-to-Net (GTN) revenue leakage. The refreshed brand … [Read more…]

Clinical leaders to share actionable insights to help post-acute providers strengthen care processes and improve patient outcomes in value-based care BALTIMORE–(BUSINESS WIRE)–Real Time Medical Systems (Real Time), the industry-leading, KLAS Rated, and HITRUST Certified post-acute analytics solution, announced today its participation in the American Association for Post-Acute Care Nursing (AAPACN) 2026 Conference, taking place March … [Read more…]

Total Expected Revenues from the Three Projects Increase from C$68 Million to C$85 Million TREVIGLIO, Italy & BURLINGTON, Ontario–(BUSINESS WIRE)–An Italian subsidiary of Anaergia Inc. (“Anaergia,” the “Company,” “we,” or “our”) (TSX: ANRG) (OTCQX: ANRGF), Anaergia S.r.l., signed amendments to three previously announced contracts with an entity owned by QGM S.à.r.l. (“QGM”), relating to the … [Read more…]

GENT, Belgium & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Europe N.V. has obtained a CE Certificate of the Lumipulse G NfL Blood assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows … [Read more…]

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Sonendo, Inc. (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today reported select preliminary financial results for the year ended December 31, 2025 and other business updates. Select Financial Updates1 Generated $28.6 million of total revenue for the full year of 2025, including $23.4 million, … [Read more…]

SALT LAKE CITY–(BUSINESS WIRE)–PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced today that it will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Tuesday, March 17, 2026. Jason Murray, Chief Executive Officer … [Read more…]

Supporting advancement of complex intranasal therapies through clinical development CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited’s (ASX:LTP) Phase II clinical study of SPONTAN®, an investigational intranasal spray … [Read more…]

Ticket sales now open; proceeds support St. Jude research and treatment ATLANTA–(BUSINESS WIRE)–Community leaders, philanthropists, and advocates across Georgia will gather for the 12th annual St. Jude Evening of Hope Gala, presented by longtime supporter HD Supply, on Saturday, April 18, 2026, at the InterContinental Buckhead Hotel. The event brings together supporters to celebrate and … [Read more…]

PITTSBURGH–(BUSINESS WIRE)–Mark Farrah Associates (MFA), https://www.markfarrah.com/, recently released a brief presenting a comparative analysis of the top Medicare Advantage (MA) plans for Maricopa County in Arizona (AZ) using new comparison tools found only in MFA’s Medicare Benefits Analyzer™ (MBA) product, a subscription-based dataset providing customers easy access to monthly enrollment information, as well as competitive … [Read more…]

Proven leader with over 15 years of experience successfully implementing financial and operational strategies across biotech industry WALTHAM, Mass.–(BUSINESS WIRE)–Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that Mark Vignola, Ph.D., has joined as Chief Financial Officer (CFO). Dr. … [Read more…]